<p>Currently, antimicrobial resistance (AMR) poses a major public health challenge. The emergence of AMR, which significantly threatens public health, is primarily due to the overuse of antimicrobial agents. This study explored the possibility that the ethical dilemmas inherent in the context of AMR may hinder the adoption of diagnostic artificial intelligence (AI). We conducted a web survey across eight countries/areas to assess public preference between two hypothetical AI types: one prioritizing individual health and the other considering the global AMR threat. Our results revealed a societal preference for the utilization of both AI types, reflecting a conflict between recognizing the significance of AMR and the desire for individualized treatment. Interestingly, the survey indicated significant gender and age differences in AI preferences, and the majority of respondents opposed the idea of AI standardization in treatment. These findings highlight the challenges of incorporating AI into public health and the necessity of considering public sentiment in addressing global health issues such as AMR.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Barriers to the widespread adoption of diagnostic artificial intelligence for preventing antimicrobial resistance

  • Hiromu Ito,
  • Takayuki Wada,
  • Genki Ichinose,
  • Jun Tanimoto,
  • Jin Yoshimura,
  • Taro Yamamoto,
  • Satoru Morita

摘要

Currently, antimicrobial resistance (AMR) poses a major public health challenge. The emergence of AMR, which significantly threatens public health, is primarily due to the overuse of antimicrobial agents. This study explored the possibility that the ethical dilemmas inherent in the context of AMR may hinder the adoption of diagnostic artificial intelligence (AI). We conducted a web survey across eight countries/areas to assess public preference between two hypothetical AI types: one prioritizing individual health and the other considering the global AMR threat. Our results revealed a societal preference for the utilization of both AI types, reflecting a conflict between recognizing the significance of AMR and the desire for individualized treatment. Interestingly, the survey indicated significant gender and age differences in AI preferences, and the majority of respondents opposed the idea of AI standardization in treatment. These findings highlight the challenges of incorporating AI into public health and the necessity of considering public sentiment in addressing global health issues such as AMR.